# Effectiveness of Glunovo Real-Time Continuous Glucose Monitoring in Adults With Type 2 Diabetes

Study · id `cardio:ct-nct07089979` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07089979](<https://clinicaltrials.gov/study/NCT07089979>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07089979

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 260 participants.

## Technical summary

Registry record NCT07089979. Randomized; no masking; primary purpose other. Start 2024-01-01 (actual); primary completion 2024-07-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 260 participants (enrolled count; ClinicalTrials.gov record NCT07089979, source copy `cardio:ctgov-nct07089979-2025-07-29`, retrieved 2026-10-26)
- Started: 2024-01-01 (actual) (ClinicalTrials.gov record NCT07089979, source copy `cardio:ctgov-nct07089979-2025-07-29`, retrieved 2026-10-26)
- Primary completion: 2024-07-01 (actual) (ClinicalTrials.gov record NCT07089979, source copy `cardio:ctgov-nct07089979-2025-07-29`, retrieved 2026-10-26)
- Completion: 2024-07-15 (actual) (ClinicalTrials.gov record NCT07089979, source copy `cardio:ctgov-nct07089979-2025-07-29`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT07089979, source copy `cardio:ctgov-nct07089979-2025-07-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07089979-2025-07-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effectiveness of Glunovo Real-Time Continuous Glucose Monitoring in Adults With Type 2 Diabetes
- Acronym: GCR
- Condition: Glucose Monitoring, Continuous
- Intervention (Device): Glunovo CGM device
- Intervention (Device): BG-meter
- Lead sponsor: University of Milan
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: University of Milan (`cardio:org-university-of-milan`)

## Provenance

Content hash: fbe6111c0e637f89729d3794080815d252b0811ea9e60eb0786cbddcfcd22390
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
